Weil Company, Inc. Pfizer Inc Transaction History

Weil Company, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $758 - $877	-21 Reduced 0.33%	6,308 $231,000
Q2 2021 Jul 20, 2021	SELL	$35.91 - $40.68 $5,566 - $6,305	-155 Reduced 2.39%	6,329 $248,000
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $10,047 - $11,331	300 Added 4.85%	6,484 $235,000
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $4,762 - $5,587	-150 Reduced 2.37%	6,184 $227,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $15,893 - $22,708	-588 Reduced 8.49%	6,334 $207,000
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $10,468 - $11,880	318 Added 4.82%	6,922 $271,000
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $3,249 - $4,213	100 Added 1.54%	6,604 $225,000
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $5,546 - $6,228	150 Added 2.36%	6,504 $282,000
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $896 - $1,087	26 Added 0.41%	6,354 $280,000
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $208,697 - $222,492	6,328 New	6,328 $230,000

3,257

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $151B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Weil Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Weil Company, Inc. with notifications on news.